Institutional Ownership Provectus Biopharmaceuticals, Inc. (PVCT)
This table provides information about the institutional ownership of Provectus Biopharmaceuticals, Inc. (PVCT). We have compiled data on the 7 institutions that hold shares in the stock, with a total of 229,412 shares, which have been reported (via 13F filing form) to have a value of $13,000.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Home Federal Bank Of Tennessee
|
Oct 15, 2025 Q3 2025 |
100,000
shares
|
$6,000
0.0% of portfolio
|
Q3 2017
New holding
|
|
|
Wealth Preservation Advisors, LLC
Chattanooga, TN |
Nov 14, 2025 Q3 2025 |
52,600
shares
|
$3,156
0.0% of portfolio
|
Q3 2025
Added 1.15%
|
|
|
Atlas Wealth LLC
Cincinnati, OH |
Nov 12, 2025 Q3 2025 |
26,620
shares
|
$1,597
0.0% of portfolio
|
Q4 2022
New holding
|
|
|
Lbmc Investment Advisors, LLC
|
Oct 07, 2025 Q3 2025 |
20,000
shares
|
$1,200
0.0% of portfolio
|
Q3 2024
Reduced 9.09%
|
|
|
Academy Capital Management Inc
Waco, TX |
Dec 12, 2025 Q3 2025 |
20,000
shares
|
$1,200
0.0% of portfolio
|
Q4 2023
New holding
|
|
|
Financial Symmetry Inc
Raleigh, NC |
Jul 29, 2025 Q2 2025 |
10,191
shares
|
$611
0.0% of portfolio
|
Q4 2023
New holding
|
|
|
Huntington National Bank
Columbus, OH |
Nov 12, 2025 Q3 2025 |
1
shares
|
$0
0.0% of portfolio
|
Q2 2019
New holding
|